26/04/2023 | Booklet
Innovation has become a ubiquitous topic across industries and is ever more present in life sciences, where digital transformation continues to grow in pace and magnitude, affecting all aspects of pharma companies from R&D to commercialization.
Due to the ever-expanding technological and medical advancements, staying ahead of the curve has never been more challenging, nor more critical. This has caused attitudes surrounding innovation to shift from a “nice to have” to an unquestionable factor of an organization’s success, and ability to deliver solutions that tackle the most complex challenges.
We believe that “innovation” is not something that should be relegated to one division or department. Rather, we believe it is a mindset that should be embraced across the entire organization. When it is harnessed correctly, it can act as a catalyst to drive others forward, do things that have never been done before, take measured risks, and adapt to new realities. “Innovation as Strategy” guides us as we support our clients to go beyond the status quo, challenge conventional practices and boldly try new things.
With the help of our senior leadership team, we explore our Innovation as Strategy approach, providing an overview of six areas of expertise as we strive to communicate, connect, and build future health to improve health outcomes and transform our clients’ businesses.
Paul Tunnah | Chief Content Officer & Managing Director
The future of field forces in life sciences: time to repurpose the rep?
James May | Managing Director Healthware Engage
Consumer Centricity - a peace offering